Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

4 recruiting2 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 3

2(33.3%)

6Total

N/A(4)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT07445841Not ApplicableRecruiting

Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training

Role: collaborator

NCT07065903Recruiting

Nimodipine Variability in SAH

Role: collaborator

NCT06038643Not ApplicableCompleted

Intergenerational Behavioral Intervention to Enhance Physical Activity in Older Adults at Risk for Alzheimer's Disease

Role: collaborator

NCT05268861Not ApplicableRecruiting

The Role of Cognition in Motor Learning After Stroke

Role: collaborator

NCT02490982Completed

Teriflunomide Observational Effectiveness Study

Role: collaborator

NCT02637089Unknown

Longitudinal Study of Mild Cognitive Impairment in Parkinson's Disease

Role: collaborator

NCT03243214Not ApplicableCompleted

Effect of Transcranial Magnetic Stimulation on Cognition and Neural Changes in Parkinson's Disease

Role: collaborator

NCT00029536Phase 3Completed

Progesterone vs Placebo Therapy for Women With Epilepsy

Role: collaborator

All 9 trials loaded